
Genezenrevenue & acquisition
Indianapolis, IndianaFounded 2014
Genezen was acquired.
Genezen is a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in viral vector manufacturing services.
Genezen revenue
Genezen has not published its revenue. Growjo puts it at about $48M a year (September 2024).
$0
$20M
$40M
$0
–
$48M
20142015–232024
| As of | Revenue | Source |
|---|---|---|
| Sep 2024 | $48MEST | Growjo estimate |
Who owns Genezen
Another company owns Genezen. The date and price of the deal are not on record.
Categories
How this page is sourced
1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Genezen? Join the podcast